Lv3
310 积分 2024-07-22 加入
Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism
2个月前
已完结
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?
2个月前
已完结
Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer
2个月前
已完结
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
2个月前
已完结
Real-world effectiveness and safety of recombinant human endostatin plus PD-1 inhibitors and chemotherapy as first-line treatment for EGFR/ALK-negative, advanced or metastatic non-small cell lung cancer
2个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
3个月前
已完结
Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression
3个月前
已完结
皖公网安备34019202002308
